1. Comparative effectiveness of radioembolization versus chemotherapy for unresectable hepatocellular carcinoma. (2020) Authors: Sanjeevi, S.; Duncan, C.; Wray, C. Journal: HPB Issue: Volume 22(2020)Supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Liver Transplantation Outcome in Patients With Angiographically Proven Coronary Artery Disease: A Multi‐Institutional Study. Issue 1 (5th November 2012) Authors: Wray, C.; Scovotti, J. C.; Tobis, J.; Niemann, C. U.; Planinsic, R.; Walia, A.; Findlay, J.; Wagener, G.; Cywinski, J. B.; Markovic, D.; Hughes, C.; Humar, A.; Olmos, A.; Sierra, R.; Busuttil, R.; Steadman, R. H. Journal: American journal of transplantation Issue: Volume 13:Issue 1(2013:Jan.) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Survival benefit of transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: influence of the meld score. (April 2017) Authors: Allenson, K.; Bhadkamkar, N.; Zvavanjanja, R.; Baxter, A.; Wray, C. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗